
Advancing speciality pharmaceuticals. Delivering meaningful patient value.
A speciality pharmaceutical company focused on identifying, developing, and bringing differentiated pharmaceutical products to patients and healthcare professionals, with a strategic focus on topical and oral liquid formulations.
Building a focused speciality pharmaceutical company
Healion Pharma is an emerging speciality pharmaceutical company established with a clear ambition: to identify, develop, and deliver differentiated medicines that create meaningful value for patients and healthcare professionals.
Our business model combines focused pharmaceutical expertise with a collaborative approach to product development, licensing, manufacturing, and commercialisation. Rather than pursuing a broad portfolio, we aim to build a focused, high-quality pipeline of speciality pharmaceutical products where we can establish sustainable differentiation and long-term value.
- Focus
- Topical and oral liquid pharmaceutical formulations
- Model
- Identify, collaborate and deliver — a partnership-led approach to product development
Creating value across healthcare
We believe pharmaceutical innovation is most meaningful when it translates into tangible value for patients and the wider healthcare environment.

Patients
Improved accessibility, convenience, acceptability, and quality of treatment.
Healthcare professionals
Reliable, differentiated pharmaceutical options that address practical clinical needs.
Partners
Sustainable commercial opportunities built on transparency, scientific expertise, and long-term collaboration.
Healthcare systems
Products designed to contribute to efficient and sustainable healthcare delivery.

Topical & oral liquid pharmaceuticals
Healion has a particular interest in topical and oral liquid formulations, where formulation expertise and product differentiation can contribute to improved patient experience and therapeutic outcomes.
Our portfolio strategy is centred on identifying opportunities where innovation can be achieved through formulation development, differentiated delivery, patient-friendly dosage forms, or addressing gaps in existing treatment options.
Why Healion Pharma?

Focused expertise
A clear strategic focus on speciality pharmaceuticals, with particular interest in topical and oral liquid dosage forms.
Differentiated portfolio
We actively seek opportunities that offer meaningful differentiation and address unmet or underserved healthcare needs.
Partnership-led growth
We believe sustainable growth is achieved through long-term relationships with the right scientific, manufacturing, licensing, and commercial partners.
Quality driven
Quality, regulatory compliance, patient safety, and ethical business practices underpin everything we do.
Global outlook
We actively explore opportunities with pharmaceutical partners across Europe, the United States, India, and other international markets.
Our collaboration opportunities

Co-Development
We are interested in partnering with pharmaceutical and technology companies to jointly develop differentiated pharmaceutical products. Through co-development, we aim to combine complementary scientific, technical, regulatory, and commercial capabilities to accelerate promising opportunities.
Learn more
In-Licensing
We actively evaluate in-licensing opportunities for differentiated pharmaceutical products and technologies that complement our strategic focus. We are particularly interested in opportunities with:
Learn more
Manufacturing Partnerships
We collaborate with qualified pharmaceutical manufacturing partners capable of supporting development, scale-up, technology transfer, commercial manufacturing, and supply. We seek long-term relationships with partners who share our commitment to quality, regulatory compliance, reliability, and continuous improvement.
Learn more
Strategic Commercial Partnerships
Where appropriate, we explore commercial partnerships that can support the successful introduction and expansion of our products across selected international markets.
Learn morePartner with Healion Pharma
We welcome discussions with pharmaceutical companies, biotechnology organisations, product developers, manufacturing partners, licensing teams, investors, and healthcare organisations interested in building mutually beneficial long-term relationships.